Imitrex News
Heads Up Biotech Investors - Motley Fool
Trexima is a combination of existing drugs naproxen and sumatriptan (Imitrex is the brand name) that has shown effectiveness versus placebos and both drugs ...
GSK sales flat, profit up - News & Observer
Trexima is slated to replace Imitrex, a $1.3 billion seller that will lose patent protection in 2008. GSK developed Trexima with Chapel Hill-based Pozen, ...
Citigroup Initiates Coverage on POZEN Inc (POZN) with a Buy - StreetInsider.com (subscription)
Imitrex, marketed by Glaxo (NYSE: GSK), is the leader in the triptan market, with 2006 US sales of $1.1 billion. Based on Phase III clinical trials, Trexima ...
Pozen's Trexima Begins Six Month FDA Review - Seeking Alpha
Trexima is a single tablet containing sumatriptan succinate (Imitrex, also sold by GSK) and naproxen sodium (contained in Aleve amongst other non-steroidal ...
IMITREX, migraine headache medicine - PRESS TV
If you suffer from migraines you are not alone, fortunately IMITREX a breakthrough discovery has been made specifically for migraine headaches. ...
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy ... - PR Newswire (press release)
About Imitrex(R) (sumatriptan succinate) Tablets Imitrex is a prescription medication indicated for the acute treatment of migraine in adults. ...
Trexima™ (sumatriptan/naproxen sodium) provided relief of both ... - WebWire (press release)
Imitrex is a prescription medication indicated for the acute treatment of migraine in adults. Imitrex should only be used when a clear diagnosis of migraine ...
Medicines treat, prevent migraines - Chattanooganow (subscription)
Brand names include Imitrex, Zomig, Maxalt, Amerge and Frova. Ergotamine, a medicine that's been around for many years, still comes to the rescue for many. ...
Imitrex RSS Feed